Supernus Pharmaceuticals
SUPN
SUPN
288 hedge funds and large institutions have $2.6B invested in Supernus Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 95 increasing their positions, 113 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
29% less call options, than puts
Call options by funds: $13M | Put options by funds: $18.2M
50% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 60
71% less funds holding in top 10
Funds holding in top 10: 7 → 2 (-5)
Holders
288
Holding in Top 10
2
Calls
$13M
Puts
$18.2M
Top Buyers
| 1 | +$72M | |
| 2 | +$28.6M | |
| 3 | +$17.2M | |
| 4 |
BlackRock
New York
|
+$15.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.8M |
Top Sellers
| 1 | -$48.3M | |
| 2 | -$29.3M | |
| 3 | -$29M | |
| 4 |
Renaissance Technologies
New York
|
-$21M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
-$15.2M |